DEFY Age-Related Vision Loss
Some conditions are curable. But, at this point, age-related macular degeneration (ARMD) is not one of them.
This vision-robbing condition causes your central vision to become blurred and distorted. It gradually progresses until you can’t read, drive, or recognize faces.
The good news is that it IS possible to slow the progression of ARMD, preserving your vision AND your quality of life, even if you’re already in the later stages of the disease.
The results of the AREDS and AREDS2 (age-related eye disease) studies have been available for years. They’ve made it clear that a unique combination of vision-supporting nutrients can help slow the progression from intermediate to late ARMD.
This analysis was different because it looked at the impact of these nutrients on people already in the later stages of the disease.
Retinal scans clearly showed that taking this potent combination of antioxidants and minerals slowed the rate of expansion towards the fovea by 55 percent over just three years.
The fovea is the center of the macula, where your vision is the sharpest.
In other words, this analysis revealed that this combination of nutrients can help slow disease progression even in people who already have late dry ARMD.
So, what exactly is in this vision-protecting supplement? The AREDS2 formula consists of the following:
- Vitamin C
- Vitamin E
- Lutein
- Zeaxanthin
- Zinc
- Copper
Rather than taking these individually, plenty of supplements on the market combine them for you in the exact quantities used in the studies.
If you have age-related macular degeneration, no matter how far along in the disease process you are, it could be well worth adding these vision-protecting nutrients to your regimen.
P.S. Five “grandmother” cures BOOST memory, vision, and more!
SOURCE:
Keenan TDL, Agrón E, Keane PA, Domalpally A, and Chew EY, for the AREDS and AREDS2 Research Groups. “Oral antioxidant and lutein/zeaxanthin supplements slow geographic atrophy progression to the fovea in age-related macular degeneration.” Ophthalmology. Epub July 16, 2024. doi: 10.1016/j.ophtha.2024.07.014
